Summary: LivaNova, a professional medical technological know-how organization, has appointed Ahmet Tezel as main innovation officer, helpful May possibly 13. Tezel, with in excess of 20 decades of R&D working experience, will establish an built-in innovation perform aimed at accelerating the company’s development of new systems. He joins the LivaNova government management crew, bringing experience from his past purpose as business group chairman at Johnson & Johnson MedTech. Tezel holds levels in chemical engineering from Bogazici College and the College of California-Santa Barbara.
Important Takeaways:
- LivaNova appointed Ahmet Tezel as its chief innovation officer, efficient May 13.
- Tezel provides above 20 several years of study and improvement working experience to LivaNova, received from management roles at Johnson & Johnson MedTech, Ethicon, Alcon Inc, and Allergan Inc.
- Tezel’s main job at LivaNova will be to establish an built-in innovation perform aimed at accelerating the company’s enhancement of new health care systems.
LivaNova PLC, maker of the CE-marked aura6000 hypoglossal neurostimulator for obstructive sleep apnea, announced Ahmet Tezel, PhD, will sign up for the business as main innovation officer, helpful May possibly 13.
In this recently produced posture, Tezel will leverage his occupation of much more than 20 decades in study and growth to create an built-in innovation operate at LivaNova that will speed up the company’s enhancement of new systems. In this capacity, Tezel will join the LivaNova govt management team.
“I am pretty happy to welcome Ahmet to the LivaNova group. At LivaNova, our commitment to groundbreaking innovation remains unwavering, and Ahmet’s arrival marks a substantial step in advancing this eyesight. With a remarkable monitor history, Ahmet has led teams that have developed market place-foremost technologies throughout diverse health care domains, from bariatric surgical procedures to surgical ophthalmology,” states Vladimir Makatsaria, chief government officer of LivaNova, in a release.
Tezel most recently served as business group chairman at Johnson & Johnson MedTech, main its world investigation and improvement and innovation groups. Throughout his vocation, he has held executive investigate and enhancement roles at various healthcare firms, together with Ethicon, Alcon Inc, and Allergan Inc, establishing Class III implantables and complex money devices, in accordance to a release from LivaNova.
“I look ahead to this new chapter at LivaNova, working with the group to harness their motivations and skills to generate ground breaking product or service development that produces long-time period worth for the Organization and aligns with its mission,” suggests Tezel in a launch. “I am honored to sign up for a business that has a profound effect on patients.”
Tezel gained a bachelor of science and a master of science in chemical engineering from Bogazici University in Türkiye and a doctorate in chemical engineering from the University of California-Santa Barbara, where he centered on transdermal drug shipping.
Photograph caption: Ahmet Tezel
Photo credit: LivaNova
Leave a Reply